Exploration of Homocysteine Metabolism in Cancer and Petechial Therapeutic Targets
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 3076
Special Issue Editors
Interests: molecular genetics; genetic engineering; biochemistry; cancer metastasis; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Interests: autoimmune diseases; cancer; neurological diseases; pshychiatric diseases; reactive oxygen species; reactive nitrogen species; nitric oxide; hydrogen suflide; carbon monoxide; heme oxygenase
Special Issue Information
Dear Colleagues,
Homocysteine (Hcy) is a non-essential amino acid that is produced through the one-carbon metabolism pathway. This is the only pathway that supplies methyl groups to DNA, RNA, and proteins. One-carbon metabolism via the methionine cycle is essential during nucleotide synthesis, methylation, and reductive metabolism, and this pathway supports the high proliferative rate of cancer cells. In the last two decades, several studies have shown that disruption of this pathway is linked to different systemic diseases, such as cardiovascular disorder, neurodegenerative diseases, type 2 diabetes, etc. However, very few studies have been carried out that show that increased plasma Hcy has also been closely related to cancer. Cancer cells require a constant supply of methionine from external sources (also known as the Hoffman effect), suggesting that possibly cancer cells need increased demand for metabolites derived from the one-carbon metabolism pathway. To understand this fact, we need to decode the metabolites that are generated from this one-carbon metabolism cycle.
We invite researchers to contribute to this Special Issue who are working on the generation and usage of one-carbon units in cancer. Original research articles or review articles on the innovative aspect of the exploration of possible future therapeutics that could exploit the dependency of cancer cells on one-carbon metabolism are welcome.
Dr. Avisek Majumder
Prof. Dr. Ferdinando Nicoletti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hyperhomocysteinemia
- cancer
- one carbon metabolism
- homocysteine
- cancer therapeutics
- cancer metabolism
- methionine cycle
- methylation
- epigenetics
- methyl group donor
